Physician profile
Sudhir Agarwal
NPI 1144215138
$6,459.30
in general payments reported to CMS, 2019-2025
34 companies · $1,519 in 2025
The $1,519 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $139 · 2021: $619 · 2022: $1,253 · 2023: $1,402 · 2024: $1,259 · 2025: $1,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,081 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,080.80 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,282.96 | 2019-2025 | Farxiga, Brilinta, Lokelma |
| Janssen Pharmaceuticals, INC | $485.30 | 2021-2024 | Xarelto |
| Pfizer INC. | $426.13 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $374.70 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $340.99 | 2021-2025 | Verquvo |
| Shockwave Medical, INC | $335.72 | 2025 | |
| Amgen INC. | $335.48 | 2020-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $317.88 | 2019-2025 | Jardiance |
| Medtronic, INC. | $305.74 | 2021-2024 | Linq II, Micra, Tyrx |
| Boston Scientific Corporation | $299.82 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, S-Icd System Magnet |
| Cardiva Medical, INC. | $294.98 | 2024-2025 | Optowire, Other |
| Actelion Pharmaceuticals US, INC. | $187.95 | 2022-2025 | Opsumit, Uptravi |
| Abbott Laboratories | $186.86 | 2021-2025 | Triclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $173.67 | 2019-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $118.26 | 2022-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $113.46 | 2021-2022 | |
| Acist Medical Systems, INC. | $91.63 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $73.29 | 2022-2023 | Eliquis |
| Scpharmaceuticals INC. | $64.50 | 2023-2025 | |
| Novo Nordisk INC | $62.69 | 2022-2025 | Wegovy, Ozempic |
| Abiomed | $61.49 | 2023-2025 | Impella |
| Glaxosmithkline, LLC. | $57.03 | 2020-2022 | |
| Lexicon Pharmaceuticals, INC. | $56.31 | 2023-2024 | Inpefa |
| Stimwave Technologies Incorporated | $51.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $49.59 | 2023 | |
| Irhythm Technologies, INC. | $48.33 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Opsens INC. | $44.55 | 2022 | |
| Corcept Therapeutics | $43.80 | 2025 | Korlym |
| Gilead Sciences, INC. | $41.58 | 2022-2023 | Trodelvy |
| Esperion Therapeutics, INC. | $34.33 | 2024-2025 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $29.92 | 2021-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $25.47 | 2024 | Arcalyst |
| Vital Connect, INC | $24.80 | 2023 | Vitalpatch Rtm |
| Lundbeck LLC | $19.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudhir Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.